Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.32
-0.1400-3.14%
Volume:538.53K
Turnover:2.35M
Market Cap:295.58M
PE:-2.22
High:4.59
Open:4.51
Low:4.26
Close:4.46
Loading ...

BRIEF-Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
04 Jun

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Jun

Promising Clinical Trial Results Justify Buy Rating for Olema Pharmaceuticals

TIPRANKS
·
02 Jun

Olema Pharmaceuticals: Strategic Dose Selection and Financial Projections Support Positive Outlook

TIPRANKS
·
28 May

Olema Pharmaceuticals Announces FDA Alignment on 90 mg Palazestrant Dose for Phase 3 Trials in Metastatic Breast Cancer

Reuters
·
28 May

Olema Pharmaceuticals Inc. to Participate in Jefferies Global Healthcare Conference in New York

Reuters
·
22 May

Olema Pharmaceuticals Is Maintained at Buy by Goldman Sachs

Dow Jones
·
14 May

Olema Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $28 From $30

THOMSON REUTERS
·
14 May

Olema Pharmaceuticals: Promising Clinical Trials and Strategic Advancements Drive Buy Rating

TIPRANKS
·
14 May

Olema Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Olema Oncology Q1 Net Income USD -30.389 Million

Reuters
·
14 May

Olema Pharmaceuticals Q1 EPS $(0.36) Beats $(0.51) Estimate

Benzinga
·
14 May

Olema Pharmaceuticals Reports Q1 2025 Net Loss of $30.4M, Slightly Improved from $31.0M Loss in Q1 2024

Reuters
·
14 May

Olema Oncology Reports First Quarter 2025 Financial and Operating Results

THOMSON REUTERS
·
14 May

Olema Oncology Q1 Basic EPS USD -0.36

THOMSON REUTERS
·
14 May

Press Release: Olema Oncology Reports First Quarter 2025 Financial and Operating Results

Dow Jones
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Olema Pharmaceuticals Inc. to Participate in H.C. Wainwright Annual BioConnect Investor Conference

Reuters
·
10 May

Top Premarket Decliners

MT Newswires Live
·
05 May

Olema Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview

Reuters
·
02 May